EUVIMEDEUVIMED entdecken
Open Access

Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults

Thomas Bettuzzi, Bénédicte Lebrun-Vignes, Saskia Ingen-Housz-Oro, Emilie Sbidian

JAMA Dermatology · 2024

DOI: 10.1001/jamadermatol.2024.3575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Thomas Bettuzzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service de Dermatologie, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France. Hauptthemen laut MEDLINE: Hospital Mortality, Stevens-Johnson Syndrome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The incidence of epidermal necrolysis (EN), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), varies across studies. While in-hospital mortality rates range from 15% to 20%, contributors to long-term mortality have been rarely evaluated and remain unknown.

Objective

To assess the incidence of and compare factors associated with in-hospital mortality and postdischarge mortality and sequelae among patients with EN. Design, Setting, and Participants This cohort study used French Health System data from January 1, 2013, to December 31, 2022, and included all adult patients (aged ≥18 years) with EN identified using International Statistical Classification of Diseases, Tenth Revision codes combined with a validated algorithm. Exposure Epidermal necrolysis. Main Outcomes and Measures Incidence, in-hospital mortality, postdischarge mortality, and sequelae were assessed as main outcomes. Factors associated with mortality were assessed using a multivariable Cox proportional hazards model.

Results

A total of 1221 adult patients with EN (median [IQR] age, 66 [49-79] years; 688 females [56.3%]) were included. Incidence was 2.6 (95% CI, 2.5-2.7) cases per million person-years. The in-hospital mortality rate was 19% (95% CI, 17%-21%) and postdischarge mortality rate, 15% (95% CI, 13%-17%) for an overall mortality of 34% (95% CI, 31%-36%). In multivariable analysis, factors associated with in-hospital mortality were age (adjusted hazard ratio [AHR], 1.03 per year of age; 95% CI, 1.02-1.04 per year of age), history of cancer (AHR, 2.04; 95% CI, 1.53-2.72), dementia (AHR, 1.85; 95% CI, 1.12-3.07), liver disease (AHR, 1.81; 95% CI, 1.24-2.64), and EN severity (TEN vs SJS: AHR, 2.14; 95% CI, 1.49-3.07). Cancer, liver disease, and dementia remained associated with postdischarge mortality (AHR, 3.26 [95% CI, 2.35-4.53], 1.86 [95% CI, 1.11-3.13], and 1.95 [95% CI, 1.11-3.43], respectively). Conversely, EN initial severity was not associated with mortality after hospital discharge (TEN vs SJS: AHR, 0.95; 95% CI, 0.60-1.47), but acute complications remained associated (AHR, 2.14 [95% CI, 1.26-3.63] and 2.44 [95% CI, 1.42-4.18] for acute kidney injury and sepsis, respectively). The main sequelae were ophthalmologic and mood disorders.

Conclusion

The findings of this cohort study suggest that although EN is a rare condition, it is associated with high rates of in-hospital and postdischarge mortality among patients who are older and have comorbid conditions. However, in contrast with in-hospital mortality, postdischarge mortality is not associated with EN initial severity but with acute in-hospital complications (eg, acute kidney injury and sepsis). Future studies are needed to construct models to estimate long-term outcomes and sequelae in patients with EN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hospital MortalityStevens-Johnson SyndromeHumansFemaleMaleMiddle AgedIncidenceAgedAdultFranceCohort StudiesRisk FactorsTime FactorsPatient DischargeRetrospective StudiesYoung Adult

Autor:innen und Institutionen

  • Service de Dermatologie, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France.
  • Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE), Université Paris Est Créteil (UPEC), Créteil, France.
  • Centre de Référence des Dermatoses Bulleuses Toxiques et Toxidermies Graves, TOXIBUL, Créteil, France.
  • Service de Pharmacologie Médicale, Centre Régional de Pharmacovigilance, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Centre d'Investigation Clinique 1430, Institut National de la Santé et de la Recherche Médicale (INSERM), Créteil, France.

Zitieren

APA

Bettuzzi, T., Lebrun-Vignes, B., Ingen-Housz-Oro, S., & Sbidian, E. (2024). Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.3575

Vancouver

Bettuzzi T, Lebrun-Vignes B, Ingen-Housz-Oro S, Sbidian E. Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2024.3575

BibTeX
@article{Bettuzzi2024,
  author = {Bettuzzi, Thomas and Lebrun-Vignes, Bénédicte and Ingen-Housz-Oro, Saskia and Sbidian, Emilie},
  title = {Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults},
  journal = {JAMA Dermatology},
  year = {2024},
  doi = {10.1001/jamadermatol.2024.3575}
}
Kostenlos starten →